OPKO Health Total Long-Term Assets 2010-2024 | OPK
OPKO Health total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
| OPKO Health Annual Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2023 | $1,702 |
| 2022 | $1,773 |
| 2021 | $1,577 |
| 2020 | $1,950 |
| 2019 | $1,985 |
| 2018 | $2,133 |
| 2017 | $2,241 |
| 2016 | $2,283 |
| 2015 | $2,345 |
| 2014 | $1,125 |
| 2013 | $1,149 |
| 2012 | $211 |
| 2011 | $130 |
| 2010 | $20 |
| 2009 | $24 |
| OPKO Health Quarterly Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024-06-30 | $1,622 |
| 2024-03-31 | $1,583 |
| 2023-12-31 | $1,702 |
| 2023-09-30 | $1,699 |
| 2023-06-30 | $1,725 |
| 2023-03-31 | $1,763 |
| 2022-12-31 | $1,773 |
| 2022-09-30 | $1,811 |
| 2022-06-30 | $1,875 |
| 2022-03-31 | $1,553 |
| 2021-12-31 | $1,577 |
| 2021-09-30 | $1,860 |
| 2021-06-30 | $1,875 |
| 2021-03-31 | $1,921 |
| 2020-12-31 | $1,950 |
| 2020-09-30 | $1,943 |
| 2020-06-30 | $1,964 |
| 2020-03-31 | $1,958 |
| 2019-12-31 | $1,985 |
| 2019-09-30 | $2,077 |
| 2019-06-30 | $2,112 |
| 2019-03-31 | $2,140 |
| 2018-12-31 | $2,133 |
| 2018-09-30 | $2,191 |
| 2018-06-30 | $2,209 |
| 2018-03-31 | $2,230 |
| 2017-12-31 | $2,241 |
| 2017-09-30 | $2,291 |
| 2017-06-30 | $2,296 |
| 2017-03-31 | $2,300 |
| 2016-12-31 | $2,283 |
| 2016-09-30 | $2,298 |
| 2016-06-30 | $2,268 |
| 2016-03-31 | $2,340 |
| 2015-12-31 | $2,345 |
| 2015-09-30 | $2,498 |
| 2015-06-30 | $1,247 |
| 2015-03-31 | $1,118 |
| 2014-12-31 | $1,125 |
| 2014-09-30 | $1,132 |
| 2014-06-30 | $1,144 |
| 2014-03-31 | $1,150 |
| 2013-12-31 | $1,149 |
| 2013-09-30 | $1,142 |
| 2013-06-30 | $411 |
| 2013-03-31 | $416 |
| 2012-12-31 | $211 |
| 2012-09-30 | $162 |
| 2012-06-30 | $138 |
| 2012-03-31 | $132 |
| 2011-12-31 | $130 |
| 2011-09-30 | $33 |
| 2011-06-30 | $33 |
| 2011-03-31 | $34 |
| 2010-12-31 | $20 |
| 2010-09-30 | $23 |
| 2010-06-30 | $23 |
| 2010-03-31 | $24 |
| 2009-12-31 | $24 |
| 2009-09-30 | $12 |
| 2009-06-30 | $10 |
| 2009-03-31 | $8 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.060B | $0.864B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $211.041B | 25.75 |
| Intuitive Surgical (ISRG) | United States | $191.072B | 99.90 |
| Alcon (ALC) | Switzerland | $45.679B | 32.16 |
| IQVIA Holdings (IQV) | United States | $39.790B | 21.92 |
| Edwards Lifesciences (EW) | United States | $39.062B | 24.81 |
| IDEXX Laboratories (IDXX) | United States | $35.479B | 41.78 |
| DexCom (DXCM) | United States | $27.326B | 41.15 |
| Waters (WAT) | United States | $22.831B | 33.76 |
| SONOVA HOLDING (SONVY) | Switzerland | $22.110B | 0.00 |
| STERIS (STE) | Ireland | $21.616B | 24.91 |
| Hologic (HOLX) | United States | $18.294B | 19.30 |
| Sysmex ADR (SSMXY) | Japan | $12.864B | 40.34 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.499B | 12.83 |
| Globus Medical (GMED) | United States | $10.952B | 27.89 |
| Teleflex (TFX) | United States | $9.082B | 14.49 |
| Penumbra (PEN) | United States | $9.075B | 88.89 |
| Masimo (MASI) | United States | $8.696B | 42.08 |
| Glaukos (GKOS) | United States | $7.816B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.170B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.587B | 26.00 |
| Inari Medical (NARI) | United States | $3.009B | 0.00 |
| TransMedics (TMDX) | United States | $2.886B | 91.47 |
| LivaNova (LIVN) | United Kingdom | $2.804B | 16.18 |
| Veracyte (VCYT) | United States | $2.802B | 84.84 |
| Nihon Kohden (NHNKY) | Japan | $2.648B | 20.12 |
| Elekta AB (EKTAY) | Sweden | $2.286B | 18.62 |
| Tandem Diabetes Care (TNDM) | United States | $2.010B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.912B | 9.99 |
| RxSight (RXST) | United States | $1.776B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.333B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.222B | 0.00 |
| Artivion (AORT) | United States | $1.203B | 79.75 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.938B | 15.95 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.741B | 0.00 |
| IRadimed (IRMD) | United States | $0.716B | 38.68 |
| Mesa Laboratories (MLAB) | United States | $0.643B | 15.22 |
| SiBone (SIBN) | United States | $0.639B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.627B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.623B | 0.00 |
| Paragon 28 (FNA) | United States | $0.597B | 0.00 |
| AxoGen (AXGN) | United States | $0.555B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.501B | 0.00 |
| CVRx (CVRX) | United States | $0.377B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.360B | 19.51 |
| ClearPoint Neuro (CLPT) | United States | $0.321B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.307B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.293B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.289B | 19.43 |
| Inogen (INGN) | United States | $0.263B | 0.00 |
| NeuroPace (NPCE) | United States | $0.219B | 0.00 |
| Accuray (ARAY) | United States | $0.216B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.213B | 0.00 |
| Nevro (NVRO) | United States | $0.189B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.189B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.158B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.132B | 0.00 |
| 908 Devices (MASS) | United States | $0.124B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.111B | 16.51 |
| EDAP TMS S.A (EDAP) | France | $0.095B | 0.00 |
| LENSAR (LNSR) | United States | $0.086B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.082B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.071B | 0.00 |
| Hyperfine (HYPR) | United States | $0.069B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | Israel | $0.057B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.056B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.054B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.050B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.043B | 0.00 |
| Envoy Medical (COCH) | United States | $0.041B | 0.00 |
| Neuronetics (STIM) | United States | $0.035B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.034B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.010B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |